Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 590

1.

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.

Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M; Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord.

J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13146. [Epub ahead of print] No abstract available.

PMID:
31136059
2.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.

J Hepatol. 2019 Aug;71(2):274-280. doi: 10.1016/j.jhep.2019.03.032. Epub 2019 Apr 6.

PMID:
30965070
3.

High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program.

Deborde M, Pereyre S, Puges M, Bébéar C, Desclaux A, Hessamfar M, Le Roy C, Le Marec F, Dabis F, Cazanave C.

Med Mal Infect. 2019 Mar 23. pii: S0399-077X(18)30660-7. doi: 10.1016/j.medmal.2019.03.007. [Epub ahead of print]

PMID:
30914213
4.

Prevalence of hepatitis C among HIV-1, HIV-2 and dually reactive patients: A multi-country cross-sectional survey in West Africa.

Ekouevi DK, Coffie PA, Tchounga BK, Poda A, Jaquet A, Dabis F, Eholie SP.

J Public Health Afr. 2018 Oct 10;9(2):871. doi: 10.4081/jphia.2018.871. eCollection 2018 Oct 1.

5.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.

Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin MA, Poizot-Martin I, Simon A, Rosenthal E, Lacombe K, Pialoux G, Bouchaud O, Gervais-Hasenknoff A, Goujard C, Piroth L, Zucman D, Dominguez S, Raffi F, Alric L, Bani-Sadr F, Lascoux-Combe C, Garipuy D, Miailhes P, Vittecoq D, Duvivier C, Aumaître H, Neau D, Morlat P, Dabis F, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group.

PLoS One. 2019 Jan 25;14(1):e0211286. doi: 10.1371/journal.pone.0211286. eCollection 2019.

6.

No effect of test and treat on sexual behaviours at population level in rural South Africa.

Rolland M, McGrath N, Tiendrebeogo T, Larmarange J, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP study group.

AIDS. 2019 Mar 15;33(4):709-722. doi: 10.1097/QAD.0000000000002104.

PMID:
30608273
7.

Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).

Gosset A, Protopopescu C, Larmarange J, Orne-Gliemann J, McGrath N, Pillay D, Dabis F, Iwuji C, Boyer S.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):375-385. doi: 10.1097/QAI.0000000000001938.

8.

Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.

Salmon-Ceron D, Nahon P, Layese R, Bourcier V, Sogni P, Bani-Sadr F, Audureau E, Merchadou L, Dabis F, Wittkop L, Roudot-Thoraval F; ANRS CO12 CirVir and ANRS CO13 HEPAVIH study groups.

Hepatology. 2018 Dec 19. doi: 10.1002/hep.30400. [Epub ahead of print]

PMID:
30569448
9.

High prevalence of binge drinking among people living with HIV in four African countries.

Nouaman MN, Vinikoor M, Seydi M, Ekouevi DK, Coffie PA, Mulenga L, Tanon A, Egger M, Dabis F, Jaquet A, Wandeler G; IeDEA.

J Int AIDS Soc. 2018 Dec;21(12):e25202. doi: 10.1002/jia2.25202.

10.

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.

Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L; ANRS CO13 Hepavih study Group.

World J Hepatol. 2018 Nov 27;10(11):856-866. doi: 10.4254/wjh.v10.i11.856.

11.

Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration.

Bernard C, Balestre E, Coffie PA, Eholie SP, Messou E, Kwaghe V, Okwara B, Sawadogo A, Abo Y, Dabis F, de Rekeneire N; International Epidemiological Database to evaluate Aids (IeDEA) West Africa Collaboration.

HIV AIDS (Auckl). 2018 Nov 16;10:239-252. doi: 10.2147/HIV.S172198. eCollection 2018.

12.

"If you are here at the clinic, you do not know how many people need help in the community": Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat.

Perriat D, Plazy M, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J; ANRS 12249 TasP Study Group.

PLoS One. 2018 Nov 9;13(11):e0202473. doi: 10.1371/journal.pone.0202473. eCollection 2018.

13.

Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.

Derache A, Iwuji CC, Danaviah S, Giandhari J, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Pillay D, Gupta RK.

J Antimicrob Chemother. 2019 Feb 1;74(2):473-479. doi: 10.1093/jac/dky428.

14.

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial.

Derache A, Iwuji CC, Baisley K, Danaviah S, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Porter K, Pillay D.

Clin Infect Dis. 2019 Jul 2;69(2):207-214. doi: 10.1093/cid/ciy881.

15.

Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?

Vourli G, Pharris A, Cazein F, Costagliola D, Dabis F, Del Amo J, Delpech V, Díaz A, Girardi E, Gourlay A, Gunsenheimer-Bartmeyer B, Hernando V, Nikolopoulos G, Porter K, Rosińska M, Sabin C, Suligoi B, Supervie V, Wit F, Touloumi G.

AIDS. 2019 Jan 27;33(1):133-143. doi: 10.1097/QAD.0000000000002034.

16.

Preface.

Levy Y, Dabis F.

J Acquir Immune Defic Syndr. 2018 Oct 1;79 Suppl 1:S1-S2. doi: 10.1097/QAI.0000000000001811. No abstract available.

PMID:
30222698
17.

The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).

Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiébaut R, Tanser F, Bärnighausen T, Pillay D, Dabis F, Orne-Gliemann J; ANRS 12249 TasP Study Group.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25128. doi: 10.1002/jia2.25128.

18.

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

HIV Med. 2018 Oct;19(9):605-618. doi: 10.1111/hiv.12639. Epub 2018 Jul 18.

PMID:
30019813
19.

Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.

Iwuji C, McGrath N, Calmy A, Dabis F, Pillay D, Newell ML, Baisley K, Porter K.

J Int AIDS Soc. 2018 Jun;21(6):e25112. doi: 10.1002/jia2.25112.

20.

Integrating Electronic Patient-Reported Outcome Measures into Routine HIV Care and the ANRS CO3 Aquitaine Cohort's Data Capture and Visualization System (QuAliV): Protocol for a Formative Research Study.

Barger D, Leleux O, Conte V, Sapparrart V, Gapillout M, Crespel I, Erramouspe M, Delveaux S, Dabis F, Bonnet F.

JMIR Res Protoc. 2018 Jun 7;7(6):e147. doi: 10.2196/resprot.9439.

21.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.

Lancet HIV. 2018 Jun;5(6):e291-e300. doi: 10.1016/S2352-3018(18)30043-2. Epub 2018 May 3.

PMID:
29731407
22.

Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk.

Mallampati D, MacLean RL, Shapiro R, Dabis F, Engelsmann B, Freedberg KA, Leroy V, Lockman S, Walensky R, Rollins N, Ciaranello A.

J Int AIDS Soc. 2018 Apr;21(4):e25107. doi: 10.1002/jia2.25107.

23.

HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.

Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, Van Nguyen K, Zaniewski E, Dabis F, Sinayobye JD, Anderegg N, Ford N, Wikramanayake R, Nash D; IeDEA Collaboration.

PLoS Med. 2018 Mar 23;15(3):e1002534. doi: 10.1371/journal.pmed.1002534. eCollection 2018 Mar.

24.

Etiology of hepatocellular carcinoma in West Africa, a case-control study.

Jaquet A, Tchounga B, Tanon A, Bagny A, Ekouevi DK, Traore HA, Sasco AJ, Maiga M, Dabis F.

Int J Cancer. 2018 Aug 15;143(4):869-877. doi: 10.1002/ijc.31393. Epub 2018 Apr 10.

PMID:
29569722
25.

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25083.

26.

Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.

Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, Dabis F, Nash D, Sinayobye JD, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies MA, Egger M; African regions of the International epidemiologic Databases to Evaluate AIDS (IeDEA).

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25084.

27.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

28.

Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa.

Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, Floyd S, Havlir D, Kamya M, Lebelonyane R, Mills LA, Okello V, Petersen M, Pillay D, Sabapathy K, Wirth K, Orne-Gliemann J, Dabis F; Universal Test and Treat Trials Consortium (UT3C).

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25048.

29.

Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies.

Arikawa S, Rollins N, Jourdain G, Humphrey J, Kourtis AP, Hoffman I, Essex M, Farley T, Coovadia HM, Gray G, Kuhn L, Shapiro R, Leroy V, Bollinger RC, Onyango-Makumbi C, Lockman S, Marquez C, Doherty T, Dabis F, Mandelbrot L, Le Coeur S, Rolland M, Joly P, Newell ML, Becquet R.

Clin Infect Dis. 2018 May 17;66(11):1668-1677. doi: 10.1093/cid/cix1102.

30.

Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.

Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Bärnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell ML, Pillay D, Dabis F; ANRS 12249 TasP Study Group.

Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.

PMID:
29199100
31.

Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic.

Tiendrebeogo T, Plazy M, Darak S, Miric M, Perez-Then E, Butsashvili M, Tchendjou P, Dabis F, Orne-Gliemann J.

BMC Public Health. 2017 Nov 25;17(1):901. doi: 10.1186/s12889-017-4901-8.

32.

Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers.

Plazy M, Perriat D, Gumede D, Boyer S, Pillay D, Dabis F, Seeley J, Orne-Gliemann J.

PLoS One. 2017 Nov 20;12(11):e0186883. doi: 10.1371/journal.pone.0186883. eCollection 2017.

33.

Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.

Coffie PA, Egger M, Vinikoor MJ, Zannou M, Diero L, Patassi A, Kuniholm MH, Seydi M, Bado G, Ocama P, Andersson MI, Messou E, Minga A, Easterbrook P, Anastos K, Dabis F, Wandeler G; IeDEA collaboration.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):706. doi: 10.1186/s12879-017-2768-z. Review.

34.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

35.

Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.

Thiébaut R, Hue S, Le Marec F, Lelièvre JD, Dupon M, Foucat E, Lazaro E, Dabis F, Duffau P, Wittkop L, Surenaud M, Pellegrin I, Lacabaratz C, Bonnet F, Lévy Y; ANRS CO3 Aquitaine Cohort.

AIDS. 2017 Nov 13;31(17):2355-2365. doi: 10.1097/QAD.0000000000001628.

PMID:
29068834
36.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).

Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group.

J Viral Hepat. 2018 Feb;25(2):171-179. doi: 10.1111/jvh.12797. Epub 2017 Nov 20.

PMID:
28984055
37.

Knowledge, behaviors, and attitudes of HIV-infected men about syphilis.

Valdes A, Cazanave C, Dabis F, Neau D, Lacoste D, Gaborieau V, Farbos S, Dworkin MS; ANRS CO3 Aquitaine Cohort.

Med Mal Infect. 2017 Nov;47(7):470-476. doi: 10.1016/j.medmal.2017.07.010. Epub 2017 Sep 22.

PMID:
28943166
38.

Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.

Carrieri MP, Protopopescu C, Marcellin F, Rosellini S, Wittkop L, Esterle L, Zucman D, Raffi F, Rosenthal E, Poizot-Martin I, Salmon-Ceron D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2017 Dec;67(6):1157-1167. doi: 10.1016/j.jhep.2017.08.005. Epub 2017 Sep 21.

PMID:
28942916
39.

Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.

Semeere A, Freeman E, Wenger M, Glidden D, Bwana M, Kanyesigye M, Asirwa FC, Rotich E, Busakhala N, Oga E, Jedy-Agba E, Kwaghe V, Iregbu K, Adebamowo C, Jaquet A, Dabis F, Phiri S, Bohlius J, Egger M, Yiannoutsos CT, Wools-Kaloustian K, Martin J.

BMC Cancer. 2017 Sep 2;17(1):611. doi: 10.1186/s12885-017-3549-1.

40.

Prevention and Care of Hepatitis B in Senegal; Awareness and Attitudes of Medical Practitioners.

Jaquet A, Wandeler G, Tine J, Diallo MB, Manga NM, Dia NM, Fall F, Dabis F, Seydi M.

Am J Trop Med Hyg. 2017 Aug;97(2):389-395. doi: 10.4269/ajtmh.17-0065.

41.

Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis.

Bernard C, Dabis F, de Rekeneire N.

PLoS One. 2017 Aug 4;12(8):e0181960. doi: 10.1371/journal.pone.0181960. eCollection 2017. Review.

42.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.

43.

We still need to beat HIV.

Dabis F, Bekker LG.

Science. 2017 Jul 20. pii: eaao4197. doi: 10.1126/science.aao4197. [Epub ahead of print] No abstract available.

PMID:
28729351
44.

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.

Coffie PA, Tchounga BK, Bado G, Kabran M, Minta DK, Wandeler G, Gottlieb GS, Dabis F, Eholie SP, Ekouevi DK.

BMC Infect Dis. 2017 Jul 4;17(1):466. doi: 10.1186/s12879-017-2568-5.

45.

Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies.

Jaquet A, Nouaman M, Tine J, Tanon A, Anoma C, Inwoley A, Attia A, Ekouevi DK, Seydi M, Dabis F, Wandeler G.

Liver Int. 2017 Aug;37(8):1116-1121. doi: 10.1111/liv.13484. Epub 2017 Jun 22.

46.

Changes in viral hepatitis B screening practices over time in West African HIV clinics.

Coffie PA, Patassi A, Doumbia A, Bado G, Messou E, Minga A, Allah-Kouadio E, Zannou DM, Seydi M, Kakou AR, Dabis F, Wandeler G.

Med Mal Infect. 2017 Oct;47(6):394-400. doi: 10.1016/j.medmal.2017.04.011. Epub 2017 May 23.

PMID:
28545675
47.

Smoking status and HIV in low-income and middle-income countries.

Jaquet A, Dabis F.

Lancet Glob Health. 2017 Jun;5(6):e557-e558. doi: 10.1016/S2214-109X(17)30179-1. No abstract available.

48.

Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.

Boucquemont J, Lawson-Ayayi S, Rigothier C, Bonnet F, Proust-Lima C, Neau D, Greib C, Miremont-Salamé G, Dabis F, Dupon M, Dauchy FA; for ANRS C03 Aquitaine Cohort Study Group.

Nephron. 2017;136(3):211-220. doi: 10.1159/000467400. Epub 2017 Apr 26.

PMID:
28445881
49.

Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).

Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salmon-Ceron D, Spire B, Roux P, Carrieri MP; ANRS CO13-HEPAVIH Study Group.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):786-791. doi: 10.1097/MEG.0000000000000883.

PMID:
28418984
50.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration; Centers for AIDS Research Network of Integrated Clinical Systems.

Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.

Supplemental Content

Support Center